S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals

Protagenic Therapeutics (PTIX) Institutional Ownership

$1.44
-0.20 (-12.20%)
(As of 04/12/2024 ET)

Institutional Ownership Changes (13F Filings) for Protagenic Therapeutics (NASDAQ:PTIX)

Current
Institutional Ownership
Percentage
7.97%
Number of
Institutional Buyers
(last 12 months)
0
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$135.28K
Get PTIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protagenic Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PTIX Institutional Buying and Selling by Quarter

Protagenic Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023Geode Capital Management LLC25,399$44K0.0%-75.5%0.588%
4/12/2023FNY Investment Advisers LLC18,750$32K0.0%-75.0%0.434%
8/13/2022Renaissance Technologies LLC50,200$36K0.0%-50.9%0.290%
5/13/2022Renaissance Technologies LLC102,200$83K0.0%+69.2%0.592%
2/1/2022FNY Investment Advisers LLC74,800$103K0.1%N/A0.441%
1/10/2022FNY Investment Advisers LLC74,800$103K0.1%N/A0.441%
11/15/2021Oracle Investment Management Inc.500,000$935K0.1%N/A2.980%
8/16/2021Squarepoint Ops LLC19,718$57K0.0%N/A0.135%
8/16/2021State Street Corp98,800$285K0.0%N/A0.675%
8/13/2021Northern Trust Corp22,485$65K0.0%N/A0.154%
8/13/2021Geode Capital Management LLC59,083$170K0.0%N/A0.403%
8/13/2021Vanguard Group Inc.20,783$60K0.0%N/A0.142%
8/11/2021Susquehanna Fundamental Investments LLC12,900$37K0.0%N/A0.088%
(Data available from 1/1/2016 forward)

PTIX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PTIX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Protagenic Therapeutics shares: Geode Capital Management LLC ($44K), and Renaissance Technologies LLC ($36K), FNY Investment Advisers LLC ($32K).Learn more on PTIX's institutional investors.

What percentage of Protagenic Therapeutics stock is owned by institutional investors?

7.97% of Protagenic Therapeutics stock is owned by institutional investors. Learn more on PTIX's institutional investor holdings.

Which institutional investors have been buying Protagenic Therapeutics stock?

The following institutional investors have purchased Protagenic Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($41.80K).

How much institutional buying is happening at Protagenic Therapeutics?

Institutional investors have bought a total of 41,800 shares in the last 24 months. This purchase volume represents approximately $34.07K in transactions.

Which Protagenic Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Protagenic Therapeutics stock in the last 24 months: Geode Capital Management LLC ($78.20K), FNY Investment Advisers LLC ($56.25K), and Renaissance Technologies LLC ($52K).

How much institutional selling is happening at Protagenic Therapeutics?

Institutional investors have sold a total of 186,446 shares in the last 24 months. This volume of shares sold represents approximately $270.24K in transactions.


This page (NASDAQ:PTIX) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners